Glycine receptor
Glycine receptor
The Glycine receptor (GlyR) is a member of a family of ligand-gated ion channels that mediate fast synaptic inhibition in the central nervous system. This receptor is predominantly expressed in the spinal cord and brainstem, where it plays a crucial role in the transmission of inhibitory post-synaptic potentials.
Structure[edit]
The Glycine receptor is a pentameric protein composed of five subunits. Each subunit is formed by four transmembrane domains (TM1-TM4) and a large extracellular N-terminal domain. The receptor's pentameric structure forms a central pore that is permeable to chloride ions when the receptor is activated by glycine.
Function[edit]
The primary function of the Glycine receptor is to mediate inhibitory neurotransmission. When glycine binds to the receptor, it causes a conformational change that opens the chloride ion channel. This allows chloride ions to flow into the neuron, which hyperpolarizes the cell membrane and inhibits the generation of action potentials.
Clinical significance[edit]
Mutations in the genes encoding the Glycine receptor subunits can lead to a range of neurological disorders, including hyperekplexia, a condition characterized by an exaggerated startle response. In addition, GlyR dysfunction has been implicated in the pathogenesis of certain types of epilepsy and chronic pain.
Pharmacology[edit]
Several drugs are known to interact with the Glycine receptor, including strychnine, which is a potent antagonist, and alcohol, which is a positive allosteric modulator. These interactions can modulate the receptor's function and have potential therapeutic applications.
See also[edit]
-
Glycine_receptor
-
Glycine receptor structure with agonists and antagonists
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian